Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: Possible relationship with FKBP51 overexpression

被引:44
作者
Komura, E
Chagraoui, H
de Mas, VM
Blanchet, B
de Sepulveda, P
Larbret, F
Larghero, J
Tulliez, M
Debili, N
Vainchenker, W
Giraudier, S
机构
[1] Inst Gustave Roussy, INSERM, U362, F-94805 Villejuif, France
[2] Hop Henri Mondor, Hematol Lab, F-94010 Creteil, France
[3] Hop Henri Mondor, Toxicol Lab, F-94010 Creteil, France
[4] INSERM, U130, F-13258 Marseille, France
[5] Hop St Louis, Lab Therapie Cellulaire, Paris, France
关键词
D O I
10.1016/S0301-472X(03)00085-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Spontaneous growth of megakaryocyte progenitors is one of the biologic hallmarks of idiopathic myelofibrosis (IMF). The molecular mechanisms underlying this hypersensitivity to cytokines are poorly understood. Using a differential display approach, we previously observed FK506 binding protein 51 (FKBP51) overexpression in pathologic megakaryocytes from IMF. Using an FKBP51-overexpressing cell line, we found sustained STAT5 activation associated with JAK2 phosphorylation. We subsequently tested whether this transcription factor was activated in patient samples. We detected a STAT5 nuclear translocation and activation in spontaneously grown megakaryocytes and in circulating CD34(+) cells from the majority of patients studied. The biologic role of this JAK/STAT pathway activation was demonstrated by inhibiting both the anti-apoptotic phenotype mediated by FKBP51 overexpression in UT7 cells and the spontaneous megakaryocytic growth by addition in culture of the JAK2 inhibitor AG490 or overexpression of a STAT5b dominant negative or SOCS-1. These results demonstrate that a constitutive STAT5 activation in IMF is indispensable for spontaneous growth of megakaryocytes. They also suggest that FKBP51 overexpression could be involved in STAT5 activation in IMF cells and in subsequent abnormal growth. (C) 2003 International Society for Experimental Hematology. Published by Elsevier Inc.
引用
收藏
页码:622 / 630
页数:9
相关论文
共 32 条
[1]  
ANGER B, 1990, LEUKEMIA, V4, P258
[2]  
Axelrad AA, 2000, BLOOD, V96, P3310
[3]  
BAUGHMAN G, 1995, MOL CELL BIOL, V15, P4395
[4]  
Castro-Malaspina H, 1984, Prog Clin Biol Res, V154, P427
[5]  
CASTROMALASPINA H, 1982, NOUV REV FR HEMATOL, V24, P221
[6]  
DEBILI N, 1995, BLOOD, V86, P2516
[7]   PROGNOSTIC CLASSIFICATION OF MYELOFIBROSIS WITH MYELOID METAPLASIA [J].
DUPRIEZ, B ;
DEMORY, JL ;
LAI, JL ;
FENAUX, P ;
BAUTERS, F .
BRITISH JOURNAL OF HAEMATOLOGY, 1989, 73 (01) :136-136
[8]   Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors [J].
Giraudier, S ;
Chagraoui, H ;
Komura, E ;
Barnache, S ;
Blanchet, B ;
LeCouedic, JP ;
Smith, DF ;
Larbret, F ;
Taksin, AL ;
Moreau-Gachelin, F ;
Casadevall, N ;
Tulliez, M ;
Hulin, A ;
Debili, N ;
Vainchenker, W .
BLOOD, 2002, 100 (08) :2932-2940
[9]   Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines [J].
Goncalves, F ;
Lacout, C ;
Féger, F ;
Cohen-Solal, K ;
Guichard, J ;
Cramer, E ;
Vainchenker, W ;
Duménil, D .
LEUKEMIA, 1998, 12 (09) :1355-1366
[10]   MEGAKARYOCYTE COLONY FORMATION IN CHRONIC MYELOID-LEUKEMIA AND MYELOFIBROSIS [J].
JUVONEN, E .
LEUKEMIA RESEARCH, 1988, 12 (09) :751-756